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Background: Previous research has shown cognitive dysfunction to be present in a significant number of
individuals with obesity. The objective of this study was to assess the neuropsychological profile of morbidly
obese patients referred to weight-loss treatment.
Methods: An extensive battery of neuropsychological tests with well-known normative data covering various
cognitive domains was administered to 96 patients. The test results were transformed to z-scores for comparisons
with normative data. As a means of determining level of cognitive impairment within the group, deficit scores were
applied. Group comparisons on the different cognitive domains were conducted between patients with depressive
symptoms and patients reporting no such symptoms.
Results: As illustrated in mean z-scores, the patients demonstrated lower performance compared to normative data
on visual memory (mean -.26, CI -.43 to -.09, p = .003), speed of information processing (mean -.22, CI -.34 to -.09,
p = .001), executive functions (mean -.28, CI -.40 to -.16, p < .001), and attention/vigilance (mean -.25, CI -.37 to -.13,
p < .001). Their performance was good on verbal fluency (mean .24, CI .04 to .44, p = .016) and verbal memory
(mean .55, CI .38 to .72, p < .001). No significant performance differences were observed in the cognitive domains
of visuospatial ability, motor function, and working memory. The deficit scores, however, revealed working memory
and motor function to be significantly impaired within the group as well. Patients with depressive symptoms
differed from patients without such symptoms on visual memory (mean .43, CI .07 to .80, p = .021).
Conclusions: Some characteristic cognitive weaknesses and strengths were evident at the group level, although
pronounced variation was observed. Deficits in executive functions, information processing, and attention should
be taken into consideration in clinical practice.
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Obesity is a complex condition, encompassing both
physiological and emotional entities [1]. Why some indi-
viduals are predisposed for severe obesity and others don’t
is not fully understood. Genetic and environmental factors
have been provided as the major causes for our growing
waistline. Recent attention has shifted towards the view
that differences in the brain could be both a consequence
of, and an explanatory factor for obesity. A growing body* Correspondence: hanna.lovise@sargenius.net
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CT, SPECT, and fMRI has demonstrated that, com-
pared with their normal-weight counterparts, middle-
aged and otherwise healthy elderly adults with obesity
are likely to demonstrate decreased blood flow in the
prefrontal cortex [2]; express greater cerebral glycolytic
metabolism, especially in the posterior cingulate gyrus
[3]; and demonstrate increased temporal lobe atrophy
and white matter disease [4–6]. More precisely, both
overweight (body-mass index [BMI] = 25–30) and obese
(BMI > 30) individuals seem to be affected by atrophy
in a wide range of brain regions, although this effect is
more prominent in the obese group [7]. There is cur-
rently a common understanding that both obesity and
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Table 1 Patient descriptive
N Mean SD Minimum Maximum
Age 96 43.55 9.25 18 60
BMI 88 42.61 5.52 31.8 59.7
WHR 87 0.96 0.10 0.46 1.17
SBP 83 139 15.58 115 187
DBP 83 85.9 8.46 60 122
Verbal comprehension
indexa
94 90.73 11.18 68 122
Perceptual organization
indexa
96 106.55 14.43 69 145
BDI-II raw score 95 10.0 9.22 0 38
BDI-II cognitive subscale 94 3.91 4.54 0 19
BDI-II non-cognitive
subscale
94 6.14 5.44 0 22
Notes: BMI body mass index, (weight/m2), WHR waist-to-hip ratio, (waist/hip),
SBP systolic blood pressure, DBP diastolic blood pressure, BDI-II Beck Depres-
sion Inventory II
aFigures are derived from the Wechsler Adult Intelligence Scale III
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the greater risk of late-onset Alzheimer’s disease (AD)
found in obese individuals [7].
Elevated body mass and central (abdominal) obesity
have been repeatedly linked to cognitive impairment
across the life span [8, 9]. Attention, memory, and ex-
ecutive function seem to be the most affected cognitive
domains, a situation that can also occur independent of
medical comorbidities in adults and adolescents [9–12].
Interestingly, intentional weight loss has been seen to
reverse cognitive deficits to a certain extent, especially
on the domains of memory [13, 14] and executive func-
tion [15]. This trend has been observed only in obese
individuals, however, and has not been documented in
cases involving subjects who are merely overweight
[16]. The relationship between obesity and cognition is
even more complex, as the composition of adipose
tissue changes over the lifespan [17]. Higher levels of
body weight in old age is associated with a lower risk of
AD and apparently slows down the clinical progression
of cognitive decline [18–20]. Our knowledge of cogni-
tive dysfunction in obese individuals is inconclusive
and limited, as the complexity of obesity as a condition
introduces many methodological concerns [21]. Neuro-
psychological functions in relation to obesity have most
often been examined with relatively few tests of cogni-
tive abilities at one administration.
The aims of our study are to explore cognitive func-
tion in mid-life obesity and the effect of depressive
symptoms on cognition in greater detail. By using a
wider array of tests, the goal is to construct a neuro-
psychological profile for this clinical group. Although
similar efforts have been made within the eating
disorder literature [22, 23], data of this type remains
limited relative to obesity. Furthermore, we wanted to
determine levels of neuropsychological impairment
among our patients by means of deficit scores, which,
in contrast to using only standardized test scores, will
give us the ability to differentiate subjects on the basis
of mild, moderate, and severe neuropsychological
deficits [24].
Methods
Study sample and geographical area
Patients diagnosed with morbid obesity and referred to
one of two obesity units within Innlandet Hospital Trust
were invited to participate in this study consecutively,
from September 2013 to March 2015. Inclusion criteria
were a) eligibility for morbid obesity (MO) treatment
according to public health-care guidelines, b) having a
BMI ≥ 40 kg/m2 or a BMI ≥ 35 kg/m2 with the presence
of a comorbidity, c) having completed ≥ 8 years of educa-
tion, and d) being between 18 and 60 years of age. A total
of 97 patients aged 18 to 60 gave their written informedconsent to participate; one patient that did complete the
inclusion and assessment was later excluded for medical
reasons, leaving 96 patients (74 female) in the analysis.
Exclusion criteria were a) history of neurological disorder
or injury (e.g. dementia, stroke, or seizures), b) moderate
or severe head injury (defined as >10-min loss of con-
sciousness), c) past or current history of severe psychiatric
illness (e.g. schizophrenia, bipolar disorder), d) past or
current history of alcohol or drug abuse, e) history of a
learning disorder, or f) developmental disabilities.
Two obesity units— the only two in this part of
Norway — provide health care services mainly to pa-
tients residing in the Hedmark and Oppland counties
in the south-east part of the country with approxi-
mately 400 000 inhabitants. Because the Free Hospital
Choice Norway Program allows patients to choose the
obesity unit they prefer, however, these units also serve
visiting patients from other parts of Norway. Compari-
sons between our sample and randomly selected pa-
tients from Hedmark or Oppland who were receiving
health-care services for their obesity at these units
could reveal no significant differences in age, weight, or
anthropometric measures (data not shown). Thus our
sample for this study, with mean (SD) age of 43.55
(9.25) years and a mean BMI of 42.62 (5.52) kg/m2
could be considered representative of this clinic popu-
lation. See Table 1 for more detailed descriptions.
Material and neuropsychological assessment
The test battery we selected was based upon earlier re-
search conducted in populations of individuals with
both morbid obesity and eating disorders, and com-
prised 15 tests with a total of 43 outcome variables.
The Delis-Kaplan Executive Function System [D-KEFS]
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cision score), Color Word Interference Test [CWIT]
(color naming, word reading, inhibition, inhibition/
switching), and Verbal Fluency Test [FAS] (letter
fluency, category fluency, category switching). The
Wechsler Memory Scale Revised [WMS-R] supplied
the Digit Span Test (forward and backwards), Logical
Memory Test (Immediate and delayed recall), and
Visual Memory (Immediate and delayed recall). The
Halstead-Reitan Battery provided the Trail Making Test
(Part A and B), Dynamometer, Grooved Pegboard Test,
and the computerized Category Test 108-card version
(total correct). We also administered the Wisconsin
Card Sorting Test [WCST] 64 Computer version (total
errors, perseverative responses), Conner’s Continuous
Performance Test II [CPT-II], Paced Auditory Serial
Addition Test [PASAT] (3 and 2 s interval), California
Verbal List Learning Test II [CVLT-II] (total recall
across trials, short free recall, delayed free recall), and
Rey-Complex Figure Test [RCFT] (copy, immediate re-
call, delayed recall). To find estimates of intellectual
function, subtests from the Wechsler Adult Intelligence
Scale 3rd Edition [WAIS-III] were used to find Verbal
Comprehension Index (Vocabulary, Similarities, and
Information), Perceptual Organization Index (Picture
Completion, Block Design, and Matrix Reasoning), and
Processing speed (The Digit Symbol). The Norwegian-
translated versions of these tests have been shown to
retain their central psychometric properties, with several
comparative studies confirming that the majority of tests
reveal only minor differences between Norwegian and US
test-performance scores [25–28].
Clinical assessment
Patients were screened for depression (Beck Depression
Inventory II), fatigue, (Fatigue Severity Scale), sleepiness
(Epworth Sleepiness Scale), psychological stress (Hopkins
Symptoms Check List 10), self-esteem (Rosenberg Self-
esteem Scale), humor (Sense of Humor Questionnaire-6),
and psychological well-being (World Health Organization
Five Well-being Index). Information regarding current
medical conditions was obtained from self-reports and
from patients’ medical records. This comprehensive as-
sessment was undertaken in order to provide additional
information that could be useful when interpreting our
data and to function as a reference on follow-up of pa-
tients. The total procedure, including clinical and neuro-
psychological testing, lasted in approximately 4.5 h.
Ethics
Approval was obtained from the Regional Committee
for Medical and Health Research Ethics (REC) Norway
in July 2012 – Reference 2012/966. All patients sought
treatment voluntarily, and were notified that their testresults would have no implications for their further
treatment provision. All participants gave their written
informed consent before being included in the study.
Data management
Raw scores on the neuropsychological tests were stan-
dardized by using the appropriate demographic normative
data for the respective test manuals, correcting for age,
sex, and education. For the RCFT Copy trial measure only,
we additionally included a group of 98 healthy US controls
(MMSE: mean 28.81 (SD) 1.190) similar to our sample in
age (mean 41.45 (SD) 11.77) and education for compari-
son with the clinical sample.
For the purpose of data analysis, the direction of
scores was reversed on tests on which higher scores
represent poorer performance (e.g. CPT-II). All scores
were converted into z-scores (mean = 0, SD = 1) for the
main analysis. Composite indices for the cognitive do-
mains visual memory, verbal memory, processing speed,
visuospatial ability, working memory, verbal fluency,
executive function, and attention/vigilance were created
by summarizing and averaging the z-scores from each of
the specific tests within that domain, except for the
visuospatial domain, in which the RCFT Copy measure
was not included, but was handled as an independent
score (see Table 2).
Deficit scores for each test score were also created as a
means of determining level of cognitive impairment
within the group. The deficit scores are constructed from
the same performance raw scores used previously in the
main analyses. Rather than using z-scores, however, we
used demographically corrected T-scores to provide im-
pairment ratings on a 5-point scale. A deficit score of 0 is
considered normal performance (T-score ≥ 40), a deficit
score of 1 equal to mild impairment (T-score = 35–39), 2
to mild-to-moderate impairment (T-score = 30–34), 3 to
moderate impairment (T-score = 25–29), 4 to moderate-
to-severe impairment (T- score = 20–24), and 5 to severe
impairment (T-score <20). Domain Deficit Scores (DDS)
were then constructed by averaging the deficit scores
within the various cognitive domains. Participants were
classified as impaired if the average of their impairment
scores were greater than .5 on a particular DDS. A Global
Impairment Score was then derived by averaging the DDS
across all tests in the battery. As with the DDS impair-
ment ratings, patients were classified as having Global Im-
pairment if they had an average deficit score above .5. The
use of the “deficit score” approach reflects our focus on
abilities that may have been affected by CNS injury or dis-
ease. It has been used in many previous studies, for instant
summarizing neuropsychological data has been used to
detect relatively “spotty” and sometimes subtle impair-
ment associated with HIV infection [29–31], schizophre-
nia [32], and has shown good sensitivity and specificity in
Table 2 Demographically adjusted performance z-scores with cognitive domains
Measure Mean (SD) Minimum Maximum t-value
CVLT Total recall .695 (1.406) −4.720 3.8
CVLT Immediate free recall .394 (1.117) −3.500 2.000
CVLT Delayed free recall .415 (1.020) −2.500 2.000
WMS-R Verbal memory 1 .567 (.871) −1.881 2.326
WMS-R Verbal memory 2 .688 (.883) −2.326 2.326
Verbal memory mean .552 (0.842) −2.011 2.256 6.391**
WMS-R Visual memory 1 .291 (.805) −1.555 2.054
WMS-R Visual memory 2 -.226 (.875) −2.326 2.326
RCFT Immediate recall -.532 (1.199) −4.900 1.600
RCFT Delayed recall -.568 (1.321) −4.900 1.800
Visual memory mean -.259 (.838) −2.692 1.895 −3.024*
D-KEFS CWIT Color naming -.382 (.807) −3.333 1.000
D-KEFS CWIT Word reading -.115 (.707) −2.333 1.000
WAIS-III Digit symbol -.326 (.742) −1.667 2.000
TMT A -.046 (1.256) −5.000 2.100
Processing speed mean -.219 (.595) −1.825 .908 −3.567*
WAIS III Block design .340 (.957) −1.667 3.000
WAIS III Matrix reasoning .361 (.875) −1.667 2.333
RCFT Copya -.036 (1.067) −3.505 1.549
Visuospatial ability mean .152 (.810) −1.766 1.835 1.838
WMS-R Digit span forward .308 (.889) −2.326 2.326
WMS-R Digit span backward .882 (1.183) −1.645 2.326
PASAT3 -.190 (1.015) −3.274 1.529
PASAT2 −1.057 (.988) −4.107 .794
Working memory mean .002 (.658) −1.418 1.450 .033
WCST Total error -.670 (.993) −3.000 2.000
WCST Perseverative responses -.503 (.777) −2.700 2.900
D-KEFS Tower total correct .203 (.701) −2.000 1.667
D-KEFS Tower precision score -.284 (.901) −2.667 3.000
TMT B -.167 (1.246) −3.900 1.800
D-KEFS CWIT Inhibition .063 (.848) −3.000 1.333
D-KEFS CWIT Inhibition/switching -.182 (1.015) −3.000 1.333
Executive function mean 1 (Tower total) -.198 (.572) −2.272 1.267 −3.290*
Executive function mean II (Tower precision) -.283 (.551) −1.772 1.156 −4.867**
D-KEFS Letter fluency .020 (1.230) −2.333 3.000
D-KEFS Category fluency .677 (1.347) 3.000 6.000
D-KEFS Category switching .031 (946) −2.333 2.333
Verbal fluency mean .243 (.967) −2.333 2.444 2.461**
(CPT-II) Omissions -.455* (1.176) −4.620 .790
Commissions -.552 (1.172) −3.689 1.429
Hit rate .470 (1.275) −3.876 3.398
Hit RT SE -.565 (1.346) −4.985 2.010
Detectability -.429 (.865) −3.302 1.674
Hit RT block change -.266 (1.087) −3.172 2.584
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Table 2 Demographically adjusted performance z-scores with cognitive domains (Continued)
Hit SE block change -.898 (1.311) −7.590 1.456
Hit RT ISI change -.034 (1.301) −4.247 2.404
Hit SE ISI change .009 (1.356) −4.462 2.672
Attention/vigilance mean -.251 (.557) −1.50 .76 −4.254**
Dynamometer Dominant hand -.109 (1.058) −2.400 2.300
Dynamometer Non-dominant hand .023 (1.076) −1.700 3.200
Pegboard Dominant hand -.247 (1.147) −5.000 2.100
Pegboard Non-dominant hand -.333 (1.329) −5.000 1.700
Motor function mean -.154 (.780) −1.750 1.350 −1.802
Notes: No normative data was available for the Category test 108-card version. Thus this test was left out from further analysis
aRCFT Copy: A US sample of 98 healthy controls similar in age and years of education were used as reference
*p-value < .05
**p-value < .001
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ratings [29, 31]. The GDS approach using a single cut-off
for detecting impairment appears to generalize to different
patient groups and even largely different test batteries
[31]. Similar to clinical ratings of neurocognitive results,
which do not let good/normal performances on some tests
or domains obscure problematic results on others, pur-
posely “ignores” test scores in the normal range [24, 33].Statistical analysis
A series of one-sample t-tests were computed in order to
determine whether the scores for the patient group dif-
fered significantly from the normative test mean, and
independent-sample t-tests were performed between the
patient group and the healthy controls on the RCFT Copy,
and between the depressive symptom patient group and
the non-depressive symptom patient group. Normality of
residuals was checked by visual inspection of Q-Q plots.
Some of the variables displayed moderate deviations from
normality. In these cases, we also computed p-values and
confidence intervals (CI) using Bootstrapping with the
bias-corrected and accelerated method (BCa) for 5000
bootstrap samples. These analyses gave essentially the
same results as the t-test-based p-values and CIs.
Participants were excluded from a specific analysis if
their data were not available for a relevant test. Because
the rules of administration for some of the neuropsycho-
logical tests (e.g. CWIT) required that the test to be
stopped if the patient did not achieve a high enough score
to reach the next level, cases had to be excluded analysis
by analysis rather than listwise.
Pearson’s correlation and multiple linear regression was
used to examine the possible relationship between obesity,
depressive symptoms, and cognitive function. Statistical
significance was set at p < .05, and 95 percent CI are re-
ported where relevant. SPSS 24.0 (IBM Corporation,
Armonk, NY, USA) was used in all statistical analysis.Results
Demographically adjusted performance scores for each in-
dividual test at the group level are presented in Table 2.
The mean z-scores on the cognitive domain indices and
95% CIs are illustrated in Fig. 1. After constructing the
composite indices for each domain, the patients’ perform-
ance remained significantly worse than the normative
means z-scores on visual memory (mean -.26, CI -.43 to
-.09, p = .003), speed of information processing (mean
-.22, CI -.34 to -.09, p = .001), executive function
(Executive function with Tower total achievement: Mean
-.20, CI -.31 to .07, p = .001; Executive function with
Tower precision: Mean -.28, CI -.40 to -.16, p < .001), and
attention/vigilance (mean -.25, CI -.37 to -.13, p < .001). In
contrast, the patients performed better than the norms on
verbal fluency (mean .24, CI .04 to .44, p = .016) and verbal
memory (mean .55, CI .38 to .72, p < .001). Furthermore,
their performance was well within normal range on motor
function (mean -.15, CI -.32 to .01, p = .075), visuospatial
ability (mean .15, CI -.01 to .31, p = .069), and working
memory (mean .002, CI -.13 to .14, p = .974). On the RCFT
Copy trial, an independent sample t-test revealed no differ-
ence between the MO-patients (mean 30.19, SD = 3.85)
and the healthy controls (mean = 30.33, SD = 3.66) on the
figure copying; t (189) = 2.55, p = .811. Group comparisons
between younger and older adults, with a cut-off value set
to 40 years of age did not reveal any significant difference
in cognitive performance. Pearson’s correlations revealed
no significant relationships between test performance and
measures of obesity in terms of BMI or waist-to-hip ratio
(WHR). Depressive symptoms correlated significantly with
visual memory (r = −.26, p = .012), and information
processing (r = −.21, p = .038). Patients with depressive
symptoms differed from patients without such symptoms
on visual memory (mean .43, CI .07 to .80, p = .021). For
an overview of the cognitive profiles of the depressive
symptoms group versus the noon-depressive symptoms
group see Fig. 2.
Fig. 1 The neuropsychological profile of the MO patients. Illustrated by mean z-scores on the cognitive domain indices and 95% CIs
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impaired (GDS ≥ .50) was 18.7%. For the assorted cog-
nitive domains, the percentages of impaired patients
(DDS ≥ .50) were 7.4% on verbal memory, 33.3% on visual
memory, 26.3% on processing speed, 9.4% on visuospatial
ability, 18.7% on verbal fluency, 33.3% on working mem-
ory, 33.0% and 36.2% on Executive function (with Tower
total correct/with Tower precision score), 32.5% on motor
function, and 44.8% on sustained attention/vigilance.
Figure 3 presents the distribution of DDS impairment
levels.Discussion
We examined the cognitive performance of a sample of
patients with morbid obesity in an effort to construct aFig. 2 Radar chart illustrating the performance of the depressive
symptoms and non-depressive symptoms groups for the different
cognitive domainsneuropsychological profile. We observed neuropsycho-
logical inefficiencies in our sample related to executive
function, attention/vigilance, processing speed, and
visual memory, albeit with great within-group variation.
Additional inefficiencies in working memory and motor
function were revealed when we applied the deficit
scores to each individual’s test performance. Most
participants performed within the normal range, but
there were subgroups that displayed specific cognitive
difficulties.
Significantly, patients performed within normal range
on visuo-constructional tasks, although with difficulty
on immediate and delayed recall memory. Although
this finding supports reduced visual memory in obesity
[10], it contradicts other studies finding a relationship
between obesity and visuo-constructional performance
[10, 12]. It is noteworthy that our sample’s poor
performance on the delayed recall tasks cannot be ex-
plained by poor memory per se, as verbal memory was
exceptionally good. Perhaps this reduced performance
on the visual recall conditions is related to the extent
to which the visual material in question was organized
and processed. Among anorexia nervosa (AN) and
bulimia nervosa (BN) patients, a focus on details rather
than on gestalt features arguably explains good accur-
acy scores followed by poor performance on visual
tasks. A similar detailed-focus style could be present
among obese people as well. To the best of our know-
ledge, only one study has investigated this idea and has
found support for it [34]. We propose that a distorted
self-perception of one’s body size, shape, and placement
in space is enhanced by two factors: an inefficient
organizational strategy for spatial material and an inability
Fig. 3 Distribution of DDS levels. Patients sorted according to being within normal range, mildly impaired, moderately impaired, and severely
impaired. Numbers reported in %
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to further accumulation of unwanted excess weight, a pos-
sibility requiring further investigation.
We also constructed two separate composite scores
representing the domain of executive function, based
upon a recommendation to use the Tower test preci-
sion score rather than the total correct score when
applying this neuropsychological test [22]. Both com-
posite scores, therefore, comprise a measure from the
Tower test: a precision score and a total correct score.
Although both composite scores revealed dysfunction
in this cognitive domain, the precision score appeared
to be a better measure of actual functioning level, as
substantiated by our findings regarding increased impul-
sivity and reduced attention spans. The actions of our pa-
tients were impulsive (e.g. on the CPT-II), with lack of
attention to neatness across tests (e.g. on the WMS-R
visual memory tasks). They often demonstrated low mo-
tivation to complete the task, particularly on the Tower
test or the PASAT (the test most subjects declined to
finish). Problems with impulsivity are suggested to be a
common trait among overweight and obese individuals. A
deficit in any aspect of executive function, such as in-
trusive thoughts and the inability to inhibit automatic
or dominant behaviors [35] may contribute to chal-
lenges with the development of alternative coping strat-
egies, rendering these patients more vulnerable to
employing unhealthy eating behaviors in response to
emotional distress [12].
Our findings are largely in line with research demon-
strating comparable results with individuals with both AN
and BN, especially on executive functioning [22, 23, 36].
Whether or not the endocrine effect of adipose tissue
on the central nervous system plays the major part in
the relationship between cognition and body weight
[37], Fagundo et al. suggest that cognitive functioningin extreme weight conditions like eating disorders and
morbid obesity have similar dysfunctional executive
profiles [36], a suggestion documented in meta-analyses
[38, 39]. Although findings are inconsistent, it has been
suggested that starvation or caloric restriction affect
cognitive performance, particularly psychomotor speed
and executive function [40]. Perhaps malnutrition in
the context of obesity is operating in pathways similar
to those seen in eating disorders; proper nutrition, it
has been suggested, could protect people from acceler-
ated cognitive decline [19, 41].
Given this hypothesis, we examined whether degree of
obesity, measured by body mass index and waist-to-hip
ratio, had any associations with cognitive task perform-
ance in our study, and found no such relationships.
Perhaps the BMIs of our patients were not high enough
relative to the sample size, and we had insufficient statis-
tical power to capture a significant difference. Although
the mean BMI in our sample classifies our subjects in
morbid obesity class III, BMI ranged from obesity class I
to III. Furthermore, nadir BMI has been found in AN
and BN patients to be a more powerful mediator for
cognitive test performance than the BMI is [23]. Perhaps
similar to patients with eating disorders in which an ex-
tremely low BMI may lead to a longer-lasting reduction
in cognitive functioning, the highest BMI acquired by a
patient may have similar effects in obesity. Alternatively,
patients with premorbid cognitive difficulties may develop
more severe obesity, rather than vice-versa. Nonetheless,
the neuropsychological performance of our group revealed
weaknesses on several cognitive tests when compared to
normative data, particularly when the deficit scores were
analyzed. A deficit score approach is recognized as an
efficient and reliable way to locate neurocognitive and
functional deficits within individuals when the goal is to
identify more severe levels of cognitive impairment [24].
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cognitive inefficiencies rather than global impairment.
Such cases will not likely be detected in standard enrol-
ment in weight-loss treatment programs, which, in turn,
may obstruct successful treatment outcomes. A patient
can appear to be within normal functioning level, but a
different story may emerge under scrutiny. The majority
of our patients were within normal functioning level when
using the GDS, but when studying each DDS, almost half
of could be classified as mildly impaired (DDS = .50–.90)
– or worse in some of the cognitive domains. More alarm-
ing, in all cognitive domains we found patients who were
both moderately (DDS = 1.0–1.39) and severely impaired
(DDS = > 1.40). Visual memory, working memory, and at-
tention/vigilance are of greatest concern among our pa-
tients according to DDS. We believe this method to have
good clinical value. The balance between sensitivity and
specificity in classifying cognitive dysfunction at a cut
point of ≥ .50 has repeatedly been supported by previous
studies using different subject samples and cognitive test
batteries, all confirming a good generalizability of this
method (e.g. Blackstone et al.). For instance, Heaton et al.
[33] performed GDS for normal healthy subjects using an
expanded Halstead-Reitan Battery. They found 11.3% of
their subjects to score within the mildly impaired range,
0.91% within the mildly to moderately impaired range,
and 0.13% scored in the moderately impaired range. Thus,
health providers must be encouraged to increase their
awareness about the most afflicted domains and be mind-
ful of the way cognitive inefficiencies can affect treatment
outcomes. A reduction in cognitive performance could be
expected if there are increasing risk factors related to age.
However, cognitive deficits seem to be present in obesity
independently of age. Our analyses could not reveal any
differences between younger and older adults within our
sample, despite a wide age range. Furthermore, it is note-
worthy that in our study, only visual memory performance
separated the depressed patients from the non-depressed.
Apart from this cognitive domain, the neuropsychological
profiles for the two groups were the same. This supports
the presence of cognitive dysfunction in this group, re-
gardless of depressive symptoms. It is easy to focus on the
patients who struggle with mood disturbances, but just as
much, patients with apparently no depressive symptoms
need to be supported. Nevertheless, depression is of some
importance regarding cognitive functioning in this patient
group.
A key strength of this study is its large sample of both
males and females. Furthermore, we employed an exten-
sive neuropsychological test battery comprised entirely
of well-established tests covering a wide range of cogni-
tive domains. Although we did not use the full-scale IQ,
we did include two indices of intellectual functioning in
our analyses.One limitation of this study that weakens the results
is the use of normative comparison data rather than a
control group for the standardized measures. Nonethe-
less, published norms are considered representative of
sociodemographic characteristics at the population
level. Second, we did not adjust for the presence of the
comorbidities that most often follow obesity, our ra-
tionale being that patients presenting for clinical treat-
ment at specialist centers most likely come from
selected subgroups significantly differing from other
populations in the first place [22]. Indeed, many pa-
tients receive treatment because of their comorbidity.
Moreover, the various comorbidities are extremely di-
verse, yet strongly intertwined and difficult to separate.
Third, we could be criticized for not considering the
issue of multiple comparisons. We believe that our
work provides a valuable piece to the jigsaw puzzle of
obesity, however, as we take comfort in Senn’s state-
ment that the methodological controversy still remains
among scientists within the field of multiplicity adjust-
ment [42] and that adjusting for multiplicity has been
argued against in many settings [43, 44].
Conclusion
The research hypothesis concerning the relationships be-
tween obesity and cognitive function is not new, however,
it is a need to specify if this clinical group’s cognitive defi-
cits represents a general cognitive decline or if it is more
specific. This study supports preceding work finding sub-
jects with morbid obesity to exhibit some cognitive weak-
nesses on executive function, memory, processing speed,
and attention/vigilance. The tests we used clearly show
that the cognitive deficits are more like specific learning
disorders. These cognitive challenges may be distinctive
for individuals with severe obesity, and may therefore be
the actual reason why many patients fail during treatment.
We argue that treatment could be better individualized
and that a successful treatment outcome could be better
facilitated by obtaining a neuropsychological profile with
complementary deficit scores of patients seeking weight-
loss treatment.
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